Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Kaohsiung J Med Sci ; 37(4): 346-347, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33340392

Asunto(s)
Infecciones por Virus de Epstein-Barr/tratamiento farmacológico , Encía/patología , Infecciones por VIH/tratamiento farmacológico , Mandíbula/patología , Linfoma Plasmablástico/tratamiento farmacológico , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Terapia Antirretroviral Altamente Activa/métodos , Biopsia , Ciclofosfamida/uso terapéutico , Doxorrubicina/uso terapéutico , Infecciones por Virus de Epstein-Barr/diagnóstico por imagen , Infecciones por Virus de Epstein-Barr/patología , Infecciones por Virus de Epstein-Barr/virología , Rayos gamma , Encía/diagnóstico por imagen , Encía/efectos de los fármacos , Encía/virología , VIH/efectos de los fármacos , VIH/crecimiento & desarrollo , Infecciones por VIH/diagnóstico por imagen , Infecciones por VIH/patología , Infecciones por VIH/virología , Herpesvirus Humano 4/efectos de los fármacos , Herpesvirus Humano 4/crecimiento & desarrollo , Humanos , Masculino , Mandíbula/diagnóstico por imagen , Mandíbula/efectos de los fármacos , Mandíbula/virología , Linfoma Plasmablástico/diagnóstico por imagen , Linfoma Plasmablástico/patología , Linfoma Plasmablástico/virología , Tomografía Computarizada por Tomografía de Emisión de Positrones , Prednisona/uso terapéutico , Costillas/diagnóstico por imagen , Costillas/efectos de los fármacos , Costillas/patología , Costillas/virología , Escápula/diagnóstico por imagen , Escápula/efectos de los fármacos , Escápula/patología , Escápula/virología , Vincristina/uso terapéutico
2.
J Pediatr Hematol Oncol ; 42(8): e822-e825, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-31567787

RESUMEN

BACKGROUND: Although complications associated with pazopanib, a multitarget tyrosine kinase inhibitor, are known, periosteal reaction as a side effect has never been reported. OBSERVATION: We present a case involving a male pediatric patient with desmoid tumors treated for 6 months with pazopanib who presented with pain and periosteal reaction in the ilium and scapula. Three months after termination of pazopanib therapy, the periosteal reaction in the scapula resolved and that in the ilium improved. CONCLUSION: Children receiving pazopanib presenting with focal pain should be examined for the periosteal reaction; this knowledge may facilitate correct diagnosis of symptoms as a drug-associated finding.


Asunto(s)
Poliposis Adenomatosa del Colon/tratamiento farmacológico , Inhibidores de la Angiogénesis/efectos adversos , Ilion/patología , Periostio/patología , Pirimidinas/efectos adversos , Escápula/patología , Sulfonamidas/efectos adversos , Poliposis Adenomatosa del Colon/patología , Adolescente , Humanos , Ilion/efectos de los fármacos , Indazoles , Masculino , Periostio/efectos de los fármacos , Pronóstico , Escápula/efectos de los fármacos
3.
Sci Rep ; 9(1): 10584, 2019 07 22.
Artículo en Inglés | MEDLINE | ID: mdl-31332285

RESUMEN

In the past few years, bisphenol A, (BPA) an endocrine-disrupting chemical, has received increasing attention because of its detrimental health effects. There is ample evidence to support that BPA interferes with the reproductive health of humans and animals. In spermatozoa, BPA-induced adverse effects are mostly caused by increased oxidative stress. Using an in vitro experimental model, we examined whether antioxidants (glutathione, vitamin C, and vitamin E) have defensive effects against BPA-induced stress in spermatozoa. The results showed that antioxidants inhibit the overproduction of reactive oxygen species (basically cellular peroxides) and increase intracellular ATP levels, thereby preventing motility loss and abnormal acrosome reaction in BPA-exposed spermatozoa. In particular, glutathione and vitamin E reduced the protein kinase A-dependent tyrosine phosphorylation in spermatozoa and, thus, prevented the precocious acrosome reaction from occurring. Furthermore, we found that the compromised fertilisation and early embryo development mediated by BPA-exposed spermatozoa can be improved following their supplementation with glutathione and vitamin E. Based on these findings, we suggest that antioxidants reduce oxidative stress in BPA-exposed spermatozoa, thus preventing detrimental effects on their function and fertility.


Asunto(s)
Antioxidantes/farmacología , Compuestos de Bencidrilo/farmacología , Fenoles/farmacología , Escápula/anomalías , Articulación del Hombro/anomalías , Animales , Ácido Ascórbico/farmacología , Compuestos de Bencidrilo/efectos adversos , Anomalías Congénitas , Glutatión/farmacología , Masculino , Ratones , Fenoles/efectos adversos , Escápula/efectos de los fármacos , Articulación del Hombro/efectos de los fármacos , Motilidad Espermática/efectos de los fármacos , Estrés Fisiológico/efectos de los fármacos , Vitamina E/farmacología
4.
Anesthesiology ; 129(1): 47-57, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29634491

RESUMEN

BACKGROUND: The interscalene nerve block provides analgesia for shoulder surgery, but is associated with diaphragm paralysis. One solution may be performing brachial plexus blocks more distally. This noninferiority study evaluated analgesia for blocks at the supraclavicular and anterior suprascapular levels, comparing them individually to the interscalene approach. METHODS: One hundred-eighty-nine subjects undergoing arthroscopic shoulder surgery were recruited to this double-blind trial and randomized to interscalene, supraclavicular, or anterior suprascapular block using 15 ml, 0.5% ropivacaine. The primary outcome was numeric rating scale pain scores analyzed using noninferiority testing. The predefined noninferiority margin was one point on the 11-point pain scale. Secondary outcomes included opioid consumption and pulmonary assessments. RESULTS: All subjects completed the study through the primary outcome analysis. Mean pain after surgery was: interscalene = 1.9 (95% CI, 1.3 to 2.5), supraclavicular = 2.3 (1.7 to 2.9), suprascapular = 2.0 (1.4 to 2.6). The primary outcome, mean pain score difference of supraclavicular-interscalene was 0.4 (-0.4 to 1.2; P = 0.088 for noninferiority) and of suprascapular-interscalene was 0.1 (-0.7 to 0.9; P = 0.012 for noninferiority). Secondary outcomes showed similar opioid consumption with better preservation of vital capacity in the anterior suprascapular group (90% baseline [P < 0.001]) and the supraclavicular group (76% [P = 0.002]) when compared to the interscalene group (67%). CONCLUSIONS: The anterior suprascapular block, but not the supraclavicular, provides noninferior analgesia compared to the interscalene approach for major arthroscopic shoulder surgery. Pulmonary function is best preserved with the anterior suprascapular nerve block.


Asunto(s)
Procedimientos Quirúrgicos Ambulatorios/efectos adversos , Anestésicos Locales/administración & dosificación , Artroscopía/efectos adversos , Bloqueo del Plexo Braquial/métodos , Dolor Postoperatorio/prevención & control , Hombro/cirugía , Adulto , Anciano , Procedimientos Quirúrgicos Ambulatorios/métodos , Artroscopía/métodos , Clavícula/efectos de los fármacos , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor/efectos de los fármacos , Dolor Postoperatorio/diagnóstico , Estudios Prospectivos , Ropivacaína/administración & dosificación , Escápula/efectos de los fármacos
5.
Sci Rep ; 7: 43425, 2017 02 24.
Artículo en Inglés | MEDLINE | ID: mdl-28233833

RESUMEN

Nanocrystalline hydroxyapatite (HA) has good biocompatibility and the potential to support bone formation. It represents a promising alternative to autologous bone grafting, which is considered the current gold standard for the treatment of low weight bearing bone defects. The purpose of this study was to compare three bone substitute pastes of different HA content and particle size with autologous bone and empty defects, at two time points (6 and 12 months) in an ovine scapula drillhole model using micro-CT, histology and histomorphometry evaluation. The nHA-LC (38% HA content) paste supported bone formation with a high defect bridging-rate. Compared to nHA-LC, Ostim® (35% HA content) showed less and smaller particle agglomerates but also a reduced defect bridging-rate due to its fast degradation The highly concentrated nHA-HC paste (48% HA content) formed oversized particle agglomerates which supported the defect bridging but left little space for bone formation in the defect site. Interestingly, the gold standard treatment of the defect site with autologous bone tissue did not improve bone formation or defect bridging compared to the empty control. We concluded that the material resorption and bone formation was highly impacted by the particle-specific agglomeration behaviour in this study.


Asunto(s)
Cementos para Huesos/farmacología , Regeneración Ósea/efectos de los fármacos , Sustitutos de Huesos/farmacología , Durapatita/farmacología , Nanopartículas/química , Herida Quirúrgica/terapia , Animales , Cementos para Huesos/química , Sustitutos de Huesos/química , Trasplante Óseo/métodos , Modelos Animales de Enfermedad , Durapatita/química , Femenino , Osteogénesis/efectos de los fármacos , Tamaño de la Partícula , Escápula/diagnóstico por imagen , Escápula/efectos de los fármacos , Escápula/lesiones , Ovinos , Herida Quirúrgica/diagnóstico por imagen , Herida Quirúrgica/patología , Herida Quirúrgica/cirugía , Trasplante Autólogo , Microtomografía por Rayos X
6.
J Emerg Med ; 52(4): 426-432, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27751698

RESUMEN

BACKGROUND: Despite being an effective analgesic for children with fractures, some clinicians may avoid prescribing ibuprofen due to its potentially harmful effect on bone healing. OBJECTIVE: To determine if exposure to ibuprofen is associated with an increased risk of bone healing complications in children with fractures. METHODS: We performed a retrospective study of children aged 6 months to 17 years who presented to the pediatric emergency department (PED) with a fracture of the tibia, femur, humerus, scaphoid, or fifth metatarsus and who followed up with the orthopedic service. We chose these fractures due to their higher risk for complications. We classified patients as exposed if they received ibuprofen in the PED or during hospitalization or were prescribed ibuprofen at discharge. The main outcome was a bone healing complication as evidenced by nonunion, delayed union, or re-displacement on follow-up radiographs. RESULTS: Of the 808 patients included in the final analysis, 338 (42%) were exposed to ibuprofen. Overall, 27 (3%) patients had a bone healing complication; 8 (1%) developed nonunion, 3 (0.4%) developed delayed union, and 16 (2%) developed re-displacement. Ten (3%) patients who were exposed to ibuprofen, and 17 (4%) who were not, developed a bone healing complication (odds ratio 0.8, 95% confidence interval 0.4-1.8; p = 0.61). There was no significant association between ibuprofen exposure and the development of a bone healing complication despite adjustment for potential confounders. CONCLUSION: Children with extremity fractures who are exposed to ibuprofen do not seem to be at increased risk for clinically important bone healing complications.


Asunto(s)
Curación de Fractura/efectos de los fármacos , Fracturas Óseas/tratamiento farmacológico , Ibuprofeno/efectos adversos , Ibuprofeno/farmacocinética , Adolescente , Analgésicos/efectos adversos , Analgésicos/farmacocinética , Analgésicos/uso terapéutico , Distribución de Chi-Cuadrado , Niño , Preescolar , Femenino , Fracturas del Fémur/tratamiento farmacológico , Humanos , Fracturas del Húmero/tratamiento farmacológico , Ibuprofeno/uso terapéutico , Lactante , Masculino , Metatarso/lesiones , Estudios Retrospectivos , Factores de Riesgo , Escápula/efectos de los fármacos , Escápula/lesiones , Fracturas de la Tibia/tratamiento farmacológico
7.
Rheumatol Int ; 34(9): 1203-9, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24553678

RESUMEN

Scapulothoracic bursitis contributes to considerable morbidity in some patients with scapular pain. A scapulothoracic bursa injection can induce symptomatic relief; however, blind injections into the scapulothoracic bursa may involve injecting into the subscapularis muscle itself. The aim of this study was to compare the therapeutic effects of intramuscular injections into the subscapularis under ultrasound (US) guidance with those of blind scapulothoracic bursa injections in patients with scapular pain. This study was a single-center, prospective, randomized, single-blinded, controlled clinical trial. Thirty-six patients with suspected scapulothoracic bursitis, who met the inclusion criteria, were recruited between January 2009 and December 2012. We performed three US-guided intramuscular injections into the subscapularis muscle or three blind scapulothoracic bursa injections at 1-week intervals. A visual analogue scale (VAS) and the Rubin scale at baseline and at 1, 2, and 3 weeks after the last injections were examined and again at 3 months after the last injections by a blinded investigator. Adverse effects were monitored. The VAS scores at baseline were 7.7 ± 1.3 and 7.8 ± 1.4 in the intramuscular injection and scapulothoracic bursa injection groups, respectively. Mean VAS scores after the intramuscular injections were 3.8, 2.7, 1.3, and 3.5, and mean VAS scores after scapulothoracic bursa injections were 4.1, 2.4, 1.6, and 2.9 at 1, 2, 3 weeks and at 3 months after the last injections. VAS scores decreased significantly after the injections in each group (p ≤ 0.05). However, no significant difference was observed between intramuscular injection into the subscapularis and the scapulothoracic bursa injection. No serious complications were encountered. In conclusion, injections at the scapulothoracic bursa without US guidance did not exclude the possibility of an effect of steroid on the subscapularis muscle, as both intramuscular injections into the subscapularis and scapulothoracic bursa injections in patients with scapular pain provided equal symptomatic relief, and all patients developed tenderness in their subscapularis muscle.


Asunto(s)
Anestésicos Locales/administración & dosificación , Bursitis/tratamiento farmacológico , Glucocorticoides/administración & dosificación , Lidocaína/administración & dosificación , Escápula/efectos de los fármacos , Dolor de Hombro/tratamiento farmacológico , Triamcinolona/administración & dosificación , Adulto , Anciano , Fenómenos Biomecánicos , Bursitis/diagnóstico , Bursitis/fisiopatología , Femenino , Humanos , Inyecciones Intraarticulares , Inyecciones Intramusculares , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Posicionamiento del Paciente , Estudios Prospectivos , Rango del Movimiento Articular , República de Corea , Escápula/diagnóstico por imagen , Escápula/fisiopatología , Dolor de Hombro/diagnóstico , Dolor de Hombro/fisiopatología , Método Simple Ciego , Factores de Tiempo , Resultado del Tratamiento , Ultrasonografía Intervencional
8.
Auton Neurosci ; 119(1): 16-24, 2005 Apr 29.
Artículo en Inglés | MEDLINE | ID: mdl-15893704

RESUMEN

Neurophysiological basis for the heterogeneity of the nerve components in the brown adipose tissue (BAT) was examined in this experiment. Efferent nerve signals were recorded from the central cut end of the small nerve filament dissected from the nerve fibers innervating the interscapular BAT (IBAT). By focusing on qualitative aspects of observed compound action potentials (spikes), we found two distinctive types of spikes exhibited by the intercostal nerves innervating IBAT. The spikes mainly appeared upon sympathetic stimulations (cold stimulation and glucose administration) were characterized by low amplitude with relatively short duration (small spike) and their sensitivity to the ganglion blocker, hexamethonium (C6). On the other hand, the spikes seen throughout the experiments were characterized by high amplitude with long duration (large spike) and their insensitivity to C6. Since BAT is activated by cold and feeding via sympathetic nervous system, the small spikes seemed to be exhibited by sympathetic fibers. On the other hand, appearance of the large C6-insensitive spikes was strongly attenuated in capsaicin-desensitized rats. Even though the functional link between IBAT and C6 insensitive fibers remains unanswered, our results suggest that IBAT is under control of various nerve types including capsaicin-sensitive fibers in addition to the control of sympathetic nervous system.


Asunto(s)
Tejido Adiposo Pardo/inervación , Tejido Adiposo Pardo/fisiología , Capsaicina/farmacología , Fibras Nerviosas/fisiología , Escápula/inervación , Escápula/fisiología , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Tejido Adiposo Pardo/efectos de los fármacos , Animales , Vías Eferentes/efectos de los fármacos , Vías Eferentes/fisiología , Hexametonio/farmacología , Masculino , Fibras Nerviosas/efectos de los fármacos , Ratas , Ratas Wistar , Escápula/efectos de los fármacos
10.
Exp Toxicol Pathol ; 52(6): 493-501, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11256751

RESUMEN

T-2 toxin (2 mg/kg b.w.) was orally inoculated to pregnant mice at gestational day (GD) 8.5, 9.5, 10.5, 11.5, 12.5, 13.5, 14.5, 15.5 and GD 16.5, respectively, and the fetuses were examined 24 hours later. The number and region of pyknotic or karyorrhectic cells varied according to inoculation date. In the GD 13.5-subgroup, a moderate to high number of pyknotic or karyorrhectic neuronal cells were observed in the central nervous system, peri-ventricular zone to subventricular zone, and pyknosis or karyorrhexis were also observed in a small number of chondroblasts and chondrocytes. In the GD 16.5-subgroup, a moderate to high number of pyknotic or karyorrhectic cells were observed in the thymus and renal subcapsular parenchyma. The nuclei of these pyknotic or karyorrhectic cells were strongly stained by the terminal deoxy nucleotidyl transferase (TdT)-mediated dUTP-digoxigenin nick end labeling method widely used for the in situ detection of apoptotic nuclei. In addition, a few fetuses from dams which were given T-2 toxin at GD 13.5 or GD 14.5 and killed at GD 17.5 showed skeletal abnormalities such as wavy ribs and short scapula. From the present findings and the well known fact that T-2 toxin readily crosses the rat placenta, it seems that T-2 toxin-induced apoptosis in the developing mouse fetuses might be a direct effect of T-2 toxin on fetuses.


Asunto(s)
Apoptosis/efectos de los fármacos , Feto/efectos de los fármacos , Toxina T-2/toxicidad , Anomalías Inducidas por Medicamentos , Administración Oral , Animales , Huesos/anomalías , Huesos/efectos de los fármacos , Sistema Nervioso Central/anomalías , Sistema Nervioso Central/efectos de los fármacos , Desarrollo Embrionario y Fetal/efectos de los fármacos , Femenino , Muerte Fetal/inducido químicamente , Peso Fetal/efectos de los fármacos , Feto/metabolismo , Técnicas para Inmunoenzimas , Ratones , Ratones Endogámicos ICR , Embarazo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Costillas/anomalías , Costillas/efectos de los fármacos , Escápula/anomalías , Escápula/efectos de los fármacos , Toxina T-2/administración & dosificación , Factores de Tiempo
11.
J Bone Miner Res ; 12(3): 332-42, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9076575

RESUMEN

Axial skeletons such as vertebrae, ribs, and scapulae develop from the embryonic somitic mesoderm through interactions with neural tube/notochord and skin ectoderm. Bone morphogenetic proteins (BMPs) seem to play important roles in these tissue interactions; however, the relationship between BMP signaling and the early development of axial skeletons is poorly understood. In this report, we investigated possible roles of BMP signaling in axial skeletal formation. First, we describe the expression patterns of BMP4 and type I receptors for BMP during somitogenesis in chick embryos based on whole mount in situ hybridization. Next, the effects of BMP on axial skeletal morphogenesis were investigated by implantation of BMP proteins into the dorsal mesoderm at the time of somitogenesis. Transcripts for both BMP4 ligand and its receptors are expressed in the dorsal ectoderm and mesoderm. Implantation of BMP4 and BMP2 into the dorsal regions of embryos result in subsequent anomalies of vertebrae, ribs, and scapulae. The effects of BMP implantation on the skeleton are shown to be dependent upon the somitic stage. Vertebral anomalies are restricted to the dorsolateral elements of the vertebrae and specifically observed after BMP implantation into embryonic day 2 (E2) embryos, but not E3 embryos. These results indicate that implantation of BMP into the dorsal part of embryos where endogenous BMP ligand and BMP receptors are expressed perturbs BMP signaling and causes axial skeletal malformations. The findings presented here suggest that BMP signaling may be involved in the early developmental process of the axial skeleton.


Asunto(s)
Proteínas Morfogenéticas Óseas/fisiología , Costillas/anomalías , Escápula/anomalías , Transducción de Señal/fisiología , Somitos/metabolismo , Columna Vertebral/anomalías , Factor de Crecimiento Transformador beta , Secuencia de Aminoácidos , Animales , Proteína Morfogenética Ósea 2 , Proteína Morfogenética Ósea 4 , Proteínas Morfogenéticas Óseas/farmacología , Cartílago/efectos de los fármacos , Cartílago/embriología , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Embrión de Pollo , ADN Complementario/aislamiento & purificación , Datos de Secuencia Molecular , Proteínas Recombinantes/farmacología , Costillas/efectos de los fármacos , Escápula/efectos de los fármacos , Homología de Secuencia de Aminoácido , Transducción de Señal/efectos de los fármacos , Somitos/efectos de los fármacos , Columna Vertebral/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA